{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:45:38Z","timestamp":1792701938409,"version":"4.5.0"},"reference-count":68,"publisher":"American Academy of Pediatrics (AAP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:p>Congenital cytomegalovirus (cCMV) infection is common because of the ubiquitous nature of the virus and the lack of an effective prevention strategy during pregnancy. Most infants with cCMV are asymptomatic, although a notable subset can have sequelae including, most commonly, sensorineural hearing loss and neurodevelopmental disability, which may not be present at birth. Timely screening for cytomegalovirus in the first weeks after birth is critical to appropriately diagnose congenital infection, evaluate affected infants, and determine the treatment course. Antiviral therapy with valganciclovir can optimize end hearing and neurodevelopmental outcomes in symptomatic infants. This review discusses the epidemiology and clinical manifestations of cCMV, targeted and universal screening approaches, and treatment and monitoring of infants with cCMV.<\/jats:p>","DOI":"10.1542\/neo.22-9-e606","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T09:27:00Z","timestamp":1630488420000},"page":"e606-e613","source":"Crossref","is-referenced-by-count":33,"title":["Congenital Cytomegalovirus Infection: Epidemiology, Timely Diagnosis, and Management"],"prefix":"10.1542","volume":"22","author":[{"given":"Carolyn M.","family":"Jenks","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Northwestern University Feinberg School of Medicine; Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Hoff","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Northwestern University Feinberg School of Medicine; Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena B.","family":"Mithal","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Northwestern University Feinberg School of Medicine; Ann & Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"issue":"1","key":"2021121008014417200_B1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"2021121008014417200_B2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"issue":"3","key":"2021121008014417200_B3","doi-asserted-by":"crossref","first-page":"e2034","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"issue":"1","key":"2021121008014417200_B4","first-page":"1","article-title":"Cytomegalovirus infection in pregnancy: review of the literature","volume":"5","author":"Bonalumi","year":"2011","journal-title":"J Prenat Med"},{"issue":"6","key":"2021121008014417200_B5","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2016.02.042","article-title":"Diagnosis and antenatal management of congenital cytomegalovirus infection","volume":"214","author":"Hughes","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2021121008014417200_B6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"issue":"2","key":"2021121008014417200_B7","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/cid\/ciq085","article-title":"Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection","volume":"52","author":"Wang","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2021121008014417200_B8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0002-9378(88)90252-9","article-title":"Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants","volume":"158","author":"Yow","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"2021121008014417200_B9","doi-asserted-by":"crossref","first-page":"e0240172","DOI":"10.1371\/journal.pone.0240172","article-title":"Maternal cytomegalovirus immune status and hearing loss outcomes in congenital cytomegalovirus-infected offspring","volume":"15","author":"Demmler-Harrison","year":"2020","journal-title":"PLoS One"},{"key":"2021121008014417200_B10","doi-asserted-by":"crossref","first-page":"104518","DOI":"10.1016\/j.jcv.2020.104518","article-title":"Maternal type of CMV infection and sequelae in infants with congenital CMV: Systematic review and meta-analysis","volume":"129","author":"Maltezou","year":"2020","journal-title":"J Clin Virol"},{"issue":"13","key":"2021121008014417200_B11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N Engl J Med"},{"issue":"14","key":"2021121008014417200_B12","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"2021121008014417200_B13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/14767058.2017.1387890","article-title":"Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid","volume":"32","author":"Bl\u00e1zquez-Gamero","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"2021121008014417200_B14","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/cid\/ciz1030","article-title":"High-dose cytomegalovirus (CMV) hyperimmune globulin and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary CMV infection","volume":"71","author":"Nigro","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10253","key":"2021121008014417200_B15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"2021121008014417200_B16","doi-asserted-by":"publisher","first-page":"462.e1","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study","volume":"215","author":"Leruez-Ville","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2021121008014417200_B17","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1093\/infdis\/jiz447","article-title":"The status of vaccine development against the human cytomegalovirus","volume":"221","author":"Plotkin","year":"2020","journal-title":"J Infect Dis"},{"issue":"2","key":"2021121008014417200_B18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jcv.2005.09.016","article-title":"Congenital cytomegalovirus (CMV) infection and hearing deficit","volume":"35","author":"Fowler","year":"2006","journal-title":"J Clin Virol"},{"issue":"3","key":"2021121008014417200_B19","doi-asserted-by":"crossref","first-page":"e20162610","DOI":"10.1542\/peds.2016-2610","article-title":"Hearing Loss in children with asymptomatic congenital cytomegalovirus infection","volume":"139","author":"Lanzieri","year":"2017","journal-title":"Pediatrics"},{"issue":"5","key":"2021121008014417200_B20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-0042-1748054","article-title":"Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus","volume":"11","author":"Dahle","year":"2000","journal-title":"J Am Acad Audiol"},{"issue":"9","key":"2021121008014417200_B21","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijporl.2005.03.011","article-title":"Audiometric, clinical and educational outcomes in a pediatric symptomatic congenital cytomegalovirus (CMV) population with sensorineural hearing loss","volume":"69","author":"Madden","year":"2005","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"10","key":"2021121008014417200_B22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3109\/14992027.2015.1046506","article-title":"Hearing configuration in children with cCMV infection and proposal of a flow chart for hearing evaluation","volume":"54","author":"Foulon","year":"2015","journal-title":"Int J Audiol"},{"issue":"5","key":"2021121008014417200_B23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ped.12122","article-title":"Risk factors for poor outcome in congenital cytomegalovirus infection and neonatal herpes on the basis of a nationwide survey in Japan","volume":"55","author":"Ito","year":"2013","journal-title":"Pediatr Int"},{"issue":"3","key":"2021121008014417200_B24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1542\/peds.99.3.409","article-title":"Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection","volume":"99","author":"Boppana","year":"1997","journal-title":"Pediatrics"},{"issue":"4","key":"2021121008014417200_B25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1542\/peds.110.4.762","article-title":"Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection","volume":"110","author":"Rivera","year":"2002","journal-title":"Pediatrics"},{"issue":"7","key":"2021121008014417200_B26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/jp.2017.41","article-title":"Long-term outcomes of children with symptomatic congenital cytomegalovirus disease","volume":"37","author":"Lanzieri","year":"2017","journal-title":"J Perinatol"},{"issue":"2","key":"2021121008014417200_B27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jcv.2005.09.016","article-title":"Congenital cytomegalovirus (CMV) infection and hearing deficit","volume":"35","author":"Fowler","year":"2006","journal-title":"J Clin Virol"},{"key":"2021121008014417200_B28","doi-asserted-by":"crossref","first-page":"104471","DOI":"10.1016\/j.jcv.2020.104471","article-title":"Low birth weight and head circumference as potential biomarkers of sensorineural hearing loss in asymptomatic congenitally CMV-infected infants","volume":"129","author":"Dimopoulou","year":"2020","journal-title":"J Clin Virol"},{"issue":"1","key":"2021121008014417200_B29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.spid.2004.09.011","article-title":"Congenital cytomegalovirus infection: outcome and diagnosis","volume":"16","author":"Ross","year":"2005","journal-title":"Semin Pediatr Infect Dis"},{"issue":"4","key":"2021121008014417200_B30","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jpeds.2013.12.007","article-title":"Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection","volume":"164","author":"Dreher","year":"2014","journal-title":"J Pediatr"},{"issue":"2","key":"2021121008014417200_B31","doi-asserted-by":"crossref","first-page":"e20170635","DOI":"10.1542\/peds.2017-0635","article-title":"Outcome of preterm infants with postnatal cytomegalovirus infection","volume":"141","author":"Gunkel","year":"2018","journal-title":"Pediatrics"},{"issue":"8","key":"2021121008014417200_B32","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1469-0691.2010.03140.x","article-title":"Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review","volume":"16","author":"Kurath","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2021121008014417200_B33","doi-asserted-by":"crossref","first-page":"e20200617","DOI":"10.1542\/peds.2020-0617","article-title":"Ethical and public health implications of targeted screening for congenital cytomegalovirus","volume":"146","author":"Gievers","year":"2020","journal-title":"Pediatrics"},{"issue":"2","key":"2021121008014417200_B34","doi-asserted-by":"crossref","first-page":"e20162128","DOI":"10.1542\/peds.2016-2128","article-title":"A targeted approach for congenital cytomegalovirus screening within newborn hearing screening","volume":"139","author":"Fowler","year":"2017","journal-title":"Pediatrics"},{"issue":"6","key":"2021121008014417200_B35","doi-asserted-by":"crossref","first-page":"e1434","DOI":"10.1542\/peds.2011-1444","article-title":"Attitudes toward newborn screening for cytomegalovirus infection","volume":"128","author":"Din","year":"2011","journal-title":"Pediatrics"},{"issue":"11","key":"2021121008014417200_B36","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/lary.28536","article-title":"Genetic testing for congenital bilateral hearing loss in the context of targeted cytomegalovirus screening","volume":"130","author":"Peterson","year":"2020","journal-title":"Laryngoscope"},{"issue":"4","key":"2021121008014417200_B37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00129492-200407000-00014","article-title":"Cochlear implantation in children deafened by cytomegalovirus: speech perception and speech intelligibility outcomes","volume":"25","author":"Ramirez Inscoe","year":"2004","journal-title":"Otol Neurotol"},{"key":"2021121008014417200_B38","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jcv.2009.08.019","article-title":"Newborn screening for congenital cytomegalovirus: Options for hospital-based and public health programs","volume":"46","author":"Grosse","year":"2009","journal-title":"J Clin Virol"},{"issue":"1","key":"2021121008014417200_B39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-3476(99)70328-8","article-title":"Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?","volume":"135","author":"Fowler","year":"1999","journal-title":"J Pediatr"},{"issue":"2","key":"2021121008014417200_B40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpeds.2004.11.020","article-title":"Screening for congenital cytomegalovirus infection: a tapestry of controversies","volume":"146","author":"Demmler","year":"2005","journal-title":"J Pediatr"},{"issue":"5","key":"2021121008014417200_B41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/rmv.1790","article-title":"Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?","volume":"24","author":"Cannon","year":"2014","journal-title":"Rev Med Virol"},{"issue":"5","key":"2021121008014417200_B42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/14787210.2017.1303377","article-title":"Encouraging postnatal cytomegalovirus (CMV) screening: the time is NOW for universal screening!","volume":"15","author":"Ronchi","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"12","key":"2021121008014417200_B43","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamapediatrics.2016.2016","article-title":"Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection","volume":"170","author":"Gantt","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"11","key":"2021121008014417200_B44","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/infdis\/jiz373","article-title":"Saliva real-time polymerase chain reaction for targeted screening of congenital cytomegalovirus infection","volume":"220","author":"Eventov-Friedman","year":"2019","journal-title":"J Infect Dis"},{"key":"2021121008014417200_B45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcv.2019.05.015","article-title":"Primary cytomegalovirus (CMV) infection in pregnancy: Diagnostic value of CMV PCR in saliva compared to urine at birth","volume":"117","author":"Exler","year":"2019","journal-title":"J Clin Virol"},{"issue":"22","key":"2021121008014417200_B46","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1006561","article-title":"Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns","volume":"364","author":"Boppana","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"2021121008014417200_B47","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/infdis\/jiy057","article-title":"Contribution of breastfeeding to false-positive saliva polymerase chain reaction for newborn congenital cytomegalovirus screening","volume":"217","author":"Ross","year":"2018","journal-title":"J Infect Dis"},{"issue":"4","key":"2021121008014417200_B48","doi-asserted-by":"crossref","first-page":"e01951-19","DOI":"10.1128\/JCM.01951-19","article-title":"Performance of the Alethia CMV Assay for detection of cytomegalovirus by use of neonatal saliva swabs","volume":"58","author":"Gantt","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2021121008014417200_B49","doi-asserted-by":"crossref","first-page":"104798","DOI":"10.1016\/j.jcv.2021.104798","article-title":"Pooled saliva CMV DNA detection: A viable laboratory technique for universal CMV screening of healthy newborns","volume":"138","author":"Shlonsky","year":"2021","journal-title":"J Clin Virol"},{"issue":"5","key":"2021121008014417200_B50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/cid\/ciq241","article-title":"Prospective identification of congenital cytomegalovirus infection in newborns using real-time polymerase chain reaction assays in dried blood spots","volume":"52","author":"Leruez-Ville","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2021121008014417200_B51","doi-asserted-by":"crossref","first-page":"e205441","DOI":"10.1001\/jamapediatrics.2020.5441","article-title":"Sensitivity of dried blood spot testing for detection of congenital cytomegalovirus infection","volume":"175","author":"Dollard","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"5","key":"2021121008014417200_B52","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/516445","article-title":"Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study","volume":"175","author":"Whitley","year":"1997","journal-title":"J Infect Dis"},{"issue":"1","key":"2021121008014417200_B53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J Pediatr"},{"key":"2021121008014417200_B54","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jcv.2009.08.012","article-title":"Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system","volume":"46","author":"Oliver","year":"2009","journal-title":"J Clin Virol"},{"issue":"6","key":"2021121008014417200_B55","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.clpt.6100150","article-title":"Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation","volume":"81","author":"Acosta","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"2021121008014417200_B56","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/528376","article-title":"Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease","volume":"197","author":"Kimberlin","year":"2008","journal-title":"J Infect Dis"},{"issue":"10","key":"2021121008014417200_B57","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N Engl J Med"},{"key":"2021121008014417200_B58","unstructured":"Genentech. Valganciclovir (valcyte) prescribing information. Available at: https:\/\/www.gene.com\/download\/pdf\/valcyte_prescribing.pdf. Accessed June 4, 2021"},{"issue":"6","key":"2021121008014417200_B59","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2021121008014417200_B60","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00431-019-03558-7","article-title":"Treatment of congenital cytomegalovirus beyond the neonatal period: an observational study","volume":"179","author":"Dorfman","year":"2020","journal-title":"Eur J Pediatr"},{"issue":"1","key":"2021121008014417200_B61","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2012.06.001","article-title":"Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period","volume":"55","author":"del Rosal","year":"2012","journal-title":"J Clin Virol"},{"issue":"9","key":"2021121008014417200_B62","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00431-010-1176-9","article-title":"Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir","volume":"169","author":"Amir","year":"2010","journal-title":"Eur J Pediatr"},{"key":"2021121008014417200_B63","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1093\/cid\/cit609","article-title":"Congenital cytomegalovirus infection: audiologic outcome","volume":"57","author":"Fowler","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2021121008014417200_B64","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.otohns.2005.08.013","article-title":"Effects of cytomegalovirus (CMV) related deafness on pediatric cochlear implant outcomes","volume":"133","author":"Lee","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"2021121008014417200_B65","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000171476","article-title":"Cochlear implant in children with asymptomatic congenital cytomegalovirus infection","volume":"14","author":"Iwasaki","year":"2009","journal-title":"Audiol Neurotol"},{"issue":"7","key":"2021121008014417200_B66","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1097\/MAO.0000000000001483","article-title":"Long-term outcomes of cochlear implantation in children with congenital cytomegalovirus infection","volume":"38","author":"Yoshida","year":"2017","journal-title":"Otol Neurotol"},{"issue":"4","key":"2021121008014417200_B67","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/MAO.0000000000002156","article-title":"Safety and effectiveness of cochlear implantation of young children, including those with complicating conditions","volume":"40","author":"Hoff","year":"2019","journal-title":"Otol Neurotol"},{"issue":"3","key":"2021121008014417200_B68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0196-0709(00)80040-X","article-title":"Performance of multiply handicapped children using cochlear implants","volume":"21","author":"Waltzman","year":"2000","journal-title":"Am J Otol"}],"container-title":["NeoReviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/22\/9\/e606\/1177970\/neoreviews_042021cmerev00064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/22\/9\/e606\/1177970\/neoreviews_042021cmerev00064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T11:33:11Z","timestamp":1673177591000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/neoreviews\/article\/22\/9\/e606\/180333\/Congenital-Cytomegalovirus-Infection-Epidemiology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":68,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,1]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/neo.22-9-e606","relation":{},"ISSN":["1526-9906"],"issn-type":[{"value":"1526-9906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}